Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
Clinical trial NCT04164459 · UNKNOWN
Trial details
- NCT number
- NCT04164459
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2019-12-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.